行情

IGC

IGC

India全球化资本
AMEX

实时行情|Nasdaq Last Sale

0.7740
-0.0160
-2.03%
盘后: 0.8100 +0.036 +4.65% 17:59 11/15 EST
开盘
0.7950
昨收
0.7900
最高
0.8150
最低
0.7600
成交量
30.54万
成交额
--
52周最高
3.300
52周最低
0.2500
市值
3,062.83万
市盈率(TTM)
-5.8904
分时
5日
1月
3月
1年
5年

IGC 新闻

  • CORRECTION: India Globalization Capital Q3 EPS $(0.03)
  • Benzinga.11/06 14:42
  • India Globalization Capital More Than Doubles Revenue, Posts Q2 Net Loss of $1.32M
  • Benzinga.11/06 14:32
  • India Globalization Capital More Than Doubles Revenue, Posts Q2 Net Loss of $1.32M
  • Benzinga.11/06 14:32
  • India Globalization Cap Q2 EPS $(0.03) Unchanged From $(0.03) YoY, Sales $1.8M Up From $811K YoY
  • Benzinga.11/06 14:31

更多

所属板块

商业支持服务
+0.23%
专业与商业服务
+0.23%

热门股票

名称
价格
涨跌幅

IGC 简况

India Globalization Capital, Inc. develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States. The Company also builds farming facilities for leasing. In Malaysia, the Company develops and manages residential and commercial real estate. In India, it leases heavy equipment. It is also focused on developing, testing and patenting phytocannabinoid-based pharmaceutical therapies and becoming a specialty pharmaceutical provider of phytocannabinoid-based pharmaceutical and nutraceutical products. It is developing a product portfolio of phytocannabinoid-based therapies for indications, including neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis. In Malaysia, the Company’s subsidiary, Cabaran Ultima Sdn. Bhd., is focused on building a five-star hotel, Genting highlands.
展开

Webull提供India Globalization Capital, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。